Intellia Therapeutics
NTLA
#5607
Rank
C$1.97 B
Marketcap
C$14.10
Share price
1.65%
Change (1 day)
18.65%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2026 (TTM): C-$4.68

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is C-$4.81. In 2025 the company made an earnings per share (EPS) of C-$5.48 an increase over its 2024 EPS that were of C-$7.51.

EPS history for Intellia Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.68-14.57%
2025C-$5.48-27.05%
2024C-$7.51-2.96%
2023C-$7.74-12.46%
2022C-$8.8464.36%
2021C-$5.3856.67%
2020C-$3.43
2018C-$2.856.99%
2017C-$2.6671.4%
2016C-$1.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.93-59.82%๐Ÿ‡บ๐Ÿ‡ธ USA